Efficacy of Shengmai injection combined with Ciwujia injection in the treatment of coronary heart disease angina pectoris

Objective: To investigate the effect of Shengmai injection combined with Ciwujia injection in the treatment of coronary heart disease (CHD) angina pectoris. Methods: In our study, 110 patients with angina pectoris were randomly divided into two groups. The control group (group A) was given the routine therapy of anti-angina pectoris. the treatment group (group B), on the basis of normal treatment, was injected with Shengmai 30ml + 5 % GS250ml 1/d and Ciwujia 40ml + 5 % GS250ml one time a day for two weeks. The symptom of angina pectoris, the changes in ECG and BF and the side effects were observed before and after treatment. Results: Angina pectoris was relieved in both groups, but the total effective rate was 76.4% in group A, and 94.5% in group B, with a significant difference between the two groups (P0.01) .The depressed ST-T segment of ECG was relieved in the two groups. The BF change in group B was significantly increased than that in group A (P0.01). No side effects were observed. Conclusion: Shengmai injection combinated with Ciwujia injection is effective in the treatment of CHD angina pectoris. No adverse reaction was found.